Shares in the Nurofen maker Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) fell 11% with the market spooked by its fourth-quarter sales miss and a £55 million revenue hit related to compliance issues at two of its Middle East operations. At 11.05 am, the stock was off 654p at 5,184p after the company revealed the trading drag was the result of lower-than-expected demand for cold and flu remedies and voluntary recall of its Nutramigen infant formula. On the issue of the adjustment to net sales, Reckitt, whic ...

Reckitt Benckiser Group shares opened 7% lower after the Anglo-Dutch consumer products group's fourth-quarter performance fell short of expectations, and an understatement in trade spend that affected its full-year net revenue figure. This underperformance was attributed to reduced sales of cold and flu products during the season. Despite this setback, Reckitt said it remains optimistic about the future, projecting a 2-4% increase in like-for-like net revenue growth for the upcoming year, with particular co ...

Any hopes that Taylor Wimpey might 'surprise on the upside' have seemingly been dashed by the CMA probe announced this week... read the preview Reckitt Benckiser's volumes will be key in its update... read the preview Takeaway group Just Eat has steadily been gaining market share from its rivals. Can it continue?... Read the preview Luxury car maker Aston Martin is expected to post a strong final quarter according to Goldman Sachs ... Read the preview Other announcements due Trading updates: Asa Internation ...

Reckitt Benckiser needs to deliver improving volumes when it reports next week, according to Mark Britzman. “Third-quarter results disappointed and the concern remains that consumers have yet to fully digest higher prices,” he adds. “Management was quick to give positive commentary on volumes, which are expected to improve over the fourth quarter. But there was no specific guidance given on when their growth might turn positive again.” If volumes can start to move in the right direction over 2024, margin ca ...

Reckitt Benckiser Group plc (OTCPK:RBGPF) CAGNY 2024 Conference Call February 22, 2024 8:00 AM ET Company Participants Kris Licht - Chief Executive Officer Shannon Eisenhardt - CFO Designate Richard Joyce - Head, Investor Relations Conference Call Participants Timothy Gamache - Weiss Multi-Strategy Advisers LLC Iain Simpson - Barclays Celine Pannuti - JPMorgan Bryan Spillane - Bank of America Timothy Gamache We have a special presentation to kick off Day 3 at CAGNY. It is my pleasure once again to welcome R ...

Hitra British consumer staples giant Reckitt Benckiser (OTCPK:RBGLY)(OTCPK:RBGPF) has continued to underwhelm, with the dollar-denominated ADSs underperforming the global peer group by circa 12ppt over the past couple of years. Performance has been similarly disappointing since I last covered the company on Seeking Alpha back in 2021, with a negative 15% total return representing nearly 20ppt of underperformance versus global peers in that time. Source: Seeking Alpha While disappointing, a little contex ...

Enfimil infant formula, made by Mead Johnson Nutrition Co., sits on display in a supermarket in New York, U.S.Baby formula maker Reckitt Benckiser's Mead Johnson Nutrition has voluntarily chosen to recall certain batches of baby formula powder due to possible bacterial contamination, according to the U.S. Food and Drug Administration.The possibly impacted batches of Nutramigen Powder, an infant formula specially designed for children allergic to cow's milk, were produced in June and distributed throughout t ...

reckitt Mucınex: Veet Enfamil Q3 TRADING AND STRATEGIC UPDATE Kris Licht Chief Executive Officer NUROFEN® neuriva DISCLAIMER Cautionary note concerning forward-looking statements This presentation contains statements with respect to the financial condition, results of operations and business of Reckitt Benckiser Group plc and the Reckitt group of companies (the "Group") and certain of the plans and objectives of the Group that are forward-looking statements. Words such as 'intends', 'targets', or the negati ...

Reckitt Benckiser Group plc (OTCPK:RBGPF) Q3 2023 Trading and Strategic Update October 25, 2023 3:00 AM ET Company Participants Richard Joyce - Head of Investor Relations, Reckitt Benckiser Group plc Kris Licht - Chief Executive Officer, Reckitt Benckiser Group plc Jeff Carr - Chief Financial Officer, Reckitt Benckiser Group plc Conference Call Participants Bruno Monteyne - Bernstein Guillaume Delmas - UBS Rashad Kawan - Morgan Stanley Iain Simpson - Barclays Alicia Forry - Investec Jeff Stent - BNP Pariba ...

Reckitt Benckiser Group plc (OTCPK:RBGPF) Q2 2023 Earnings Call Transcript July 26, 2023 8:30 AM ET Company Participants Richard Joyce - IR Nicandro Durante - CEO Jeff Carr - CFO Kris Licht - CEO Designate Conference Call Participants Tom Sykes - Deutsche Bank Jeremy Fialko - HSBC Fulvio Cazzol - Berenberg Iain Simpson - Barclays Richard Cohen - Morgan Stanley Alicia Forry - Investec Karel Zoete - Kepler Cheuvreux Operator Good morning, everyone. Welcome to Reckitt's Half Year 2023 Results Presentation. Bef ...